Boulding Mark Elliott (Officer) plans to sell ~$28K of PTC Therapeutics, Inc.
Planned, from payLoading…
PTCT · NASDAQ · Pharmaceuticals
Pharmaceuticals company based in Warren Township, New Jersey.
In the last 90 days, no insider of PTC Therapeutics, Inc. reported an open-market purchase and 1 open-market sale worth about $782K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$63.70
Last 12 months
Not enough history
Market value
Not available
Bets against the stock: 9.74M shares sold short, −0.9% vs the previous count, 11.0 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$361M
+101.5% vs the same quarter a year earlier
Free cash flow, last 12 months
−$39.8M
This quarter $127M, a year earlier −$59.6M
Net cash
$459M
Debt $591M, cash $1.05B, at Jun 30, 2026
Net income, last 12 months
−$38.4M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 30, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
1 sale
$782K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Fails to deliver: 15K shares (about $1.08M) were not delivered on time for settlement on Aug 17, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.